New Technologies in Oral Reconstructive Medicine
Consensus from the
AAP/SEPA/Osteology Workshop
Why this consensus matters
Oral reconstructive medicine is entering a new phase. Advances in scaffolds, biologics, cell therapies, digital workflows, and artificial intelligence are reshaping how clinicians approach hard- and soft-tissue regeneration around teeth and dental implants.
This workshop brought together leading international experts to assess what is already supported by evidence, what remains emerging, and how these technologies may improve patient outcomes, reduce morbidity, and enable more personalized regenerative care.
Quick facts
about the meeting
A unique collaboration between the Osteology Foundation, the AAP (American Academy of Periodontology), and the Sepa (Spanish Society of Periodontology).
42 experts from North America, Europe, and Australia collaborated to define the future of oral reconstructive medicine.
The consensus was informed by 5 commissioned systematic reviews, providing a robust scientific basis for every recommendation.
One of the first international consensus reports to explicitly discuss the role of artificial intelligence and personalized medicine in regenerative therapies.
6 reasons to read the consensus report
The Consensus workshop leads comment on the workshop outcomes.
Hover over each card to access additional related resources (requires login), or scroll further to access the full articles.

“Soft tissue substitutes, sometimes for some specific circumstances, work as well as our patient’s own tissue.”
Learn more about soft tissue graft materials
“The patient is in the center… we are actually talking about customized scaffolds that can be used for more advanced defects.”
Listen about the patient role
“Basically, the evidence is there and very promising. We need more randomized controlled trials, but initial data show they [biologics] are safe, they are a good approach, and they may offer a promising future in terms of how we correct these defects.”
More on biologics for soft tissue augmentation
“We are focusing on what we can add in terms of new technologies to make the current alternatives work better, improve our predictability, and perhaps overcome some of the barriers we have with current therapies, mainly in large bone defects.”
Read the paper of Working Group 2
“One of the exciting aspects is using AI-enabled technologies that can really help identify the characteristics of how the defects are shaped in the patient's mouth… and then these particular scaffolds or replacements can be designed that fit very closely to the patient's architecture of the defects.”
Read more about digital technologies in oral tissue regeneration
“The two major areas we covered and the most exciting areas are personalised scaffolds and emerging technologies.”
Learn more